{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:32:06Z","timestamp":1776918726131,"version":"3.51.2"},"reference-count":47,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.vaccine.2010.07.075","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T08:47:19Z","timestamp":1280998039000},"page":"6740-6748","source":"Crossref","is-referenced-by-count":39,"title":["An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor"],"prefix":"10.1016","volume":"28","author":[{"given":"Les W.","family":"Baillie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa B.","family":"Huwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Mellado-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan N.","family":"Neeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen C.","family":"Flick-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic C.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny M.","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Nataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2010.07.075_bib0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4161\/hv.9777","article-title":"Is new always better than old?: the development of human vaccines for anthrax","volume":"5","author":"Baillie","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/414837a","article-title":"Bioweapons: delivering death in the mail","volume":"414","author":"Knight","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1369-5274(00)00168-5","article-title":"Bacillus anthracis, a bug with attitude!","volume":"4","author":"Baillie","year":"2001","journal-title":"Curr Opin Microbiol"},{"issue":"6860","key":"10.1016\/j.vaccine.2010.07.075_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","article-title":"Crystal structure of the anthrax lethal factor","volume":"414","author":"Pannifer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2334-8-124","article-title":"Activity of the Bacillus anthracis 20kDa protective antigen component","volume":"8","author":"Hammamieh","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.07.075_bib0040","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/IAI.01254-08","article-title":"Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed","volume":"77","author":"Reason","year":"2009","journal-title":"Infect Immun"},{"issue":"32","key":"10.1016\/j.vaccine.2010.07.075_bib0045","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2008.05.023","article-title":"Domain specificity of the human antibody response to Bacillus anthracis protective antigen","volume":"26","author":"Reason","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.075_bib0050","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.07.075_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0928-8244(03)00085-3","article-title":"Characterisation of the immune response to the UK human anthrax vaccine","volume":"36","author":"Baillie","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.075_bib0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the UK anthrax vaccine","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"48","key":"10.1016\/j.vaccine.2010.07.075_bib0065","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.vaccine.2008.09.010","article-title":"Towards a human oral vaccine for anthrax: the utility of a Salmonella typhi Ty21a-based prime-boost immunization strategy","volume":"26","author":"Baillie","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.075_bib0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.jom.0000058345.05741.6b","article-title":"Analysis of adverse events after anthrax immunization in US army medical personnel","volume":"45","author":"Wasserman","year":"2003","journal-title":"J Occup Environ Med"},{"issue":"31","key":"10.1016\/j.vaccine.2010.07.075_bib0075","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2010.07.075_bib0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.07.075_bib0090","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CDLI.12.6.713-721.2005","article-title":"Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis","volume":"12","author":"Pittman","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.075_bib0095","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J Infect Dis"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2010.07.075_bib0100","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2010.07.075_bib0105","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0110","unstructured":"Brenneman K, Dognanay M, Akmal A, Goldman S, Galloway D, Mateczun A. The early humoral immune response to Bacillus anthracis, in preparation."},{"issue":"32","key":"10.1016\/j.vaccine.2010.07.075_bib0115","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","article-title":"Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine","volume":"25","author":"Hepburn","year":"2007","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2010.07.075_bib0120","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0264-410X(97)00132-1","article-title":"Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection","volume":"15","author":"Pomerantsev","year":"1997","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2010.07.075_bib0125","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.vaccine.2010.07.075_bib0130","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1073\/pnas.0402414101","article-title":"Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax","volume":"101","author":"Hoffmaster","year":"2004","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.vaccine.2010.07.075_bib0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.075_bib0140","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.075_bib0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/IAI.66.2.615-619.1998","article-title":"Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin","volume":"66","author":"Ballard","year":"1998","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2010.07.075_bib0150","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1073\/pnas.97.14.8027","article-title":"Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity","volume":"97","author":"Lu","year":"2000","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/504806","article-title":"Long-lasting T cell responses to biological warfare vaccines in human vaccinees","volume":"43","author":"Allen","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2004.08.007","article-title":"Production and purification of Bacillus anthracis protective antigen from Escherichia coli","volume":"38","author":"Laird","year":"2004","journal-title":"Protein Expr Purif"},{"issue":"6","key":"10.1016\/j.vaccine.2010.07.075_bib0165","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2010.07.075_bib0170","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.07.075_bib0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0180","series-title":"5th International Conference on Anthrax","article-title":"Novel mathematical approach to TNA endpoints","author":"Taylor","year":"2003"},{"issue":"10","key":"10.1016\/j.vaccine.2010.07.075_bib0185","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/IAI.73.10.6547-6551.2005","article-title":"An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin","volume":"73","author":"Lim","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2010.07.075_bib0190","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/IAI.00788-08","article-title":"Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies","volume":"77","author":"Nguyen","year":"2009","journal-title":"Infect Immun"},{"issue":"22","key":"10.1016\/j.vaccine.2010.07.075_bib0200","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1073\/pnas.93.22.12531","article-title":"Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo","volume":"93","author":"Ballard","year":"1996","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.075_bib0205","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.coi.2009.05.010","article-title":"Follicular helper T cells as cognate regulators of B cell immunity","volume":"21","author":"McHeyzer-Williams","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.07.075_bib0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.femsim.2004.05.011","article-title":"Characterization of the human immune response to the uk anthrax vaccine","volume":"42","author":"Baillie","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2010.07.075_bib0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/HAB-2003-12404","article-title":"Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model","volume":"12","author":"Zhao","year":"2003","journal-title":"Hum Antibodies"},{"issue":"1","key":"10.1016\/j.vaccine.2010.07.075_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2567.2004.01861.x","article-title":"Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?","volume":"112","author":"Gentile","year":"2004","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.075_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-8244(03)00170-6","article-title":"Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles","volume":"38","author":"Sabhnani","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.07.075_bib0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2005.01.009","article-title":"A roadmap for the immunomics of category A\u2013C pathogens","volume":"22","author":"Sette","year":"2005","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2010.07.075_bib0235","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes","volume":"184","author":"Ingram","year":"2010","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10010868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10010868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T01:40:36Z","timestamp":1591753236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10010868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":47,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0264410X10010868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}